美国肺段切除术与肺叶切除术:首原发肺癌切除后结局及第二原发肺癌治疗模式
该研究基于美国国家癌症数据库(2004-2017)分析临床IA期(≤2 cm)非小细胞肺癌患者,倾向性评分匹配后肺段切除术与肺叶切除术的总生存无显著差异(5年总生存79.9% vs 81.8%,P=.72),各亚组结果相似;监测、流行病学和最终结果数据库分析显示两种术后第二原发肺癌治疗模式无显著差异。
要点
- 在23,286例患者中,1397例(6.0%)行肺段切除术,21,889例(94.0%)行肺叶切除术。
- 倾向性评分匹配后,肺段切除与肺叶切除的5年总生存分别为79.9%与81.8%,无显著差异(P=.72)。
- 按肿瘤分级和組織学亚组分析,肺段切除与肺叶切除的总生存均相似。
核心结论
- 在美国临床IA期(≤2 cm)非小细胞肺癌患者中,肺段切除术与肺叶切除术的总生存无显著差异,总体队列及按肿瘤分级或組織学亚组分析均如此。
研究设计与样本
- 研究识别美国国家癌症数据库中2004-2017年诊断为临床IA期(≤2 cm)非小细胞肺癌并接受肺段切除术或肺叶切除术的患者,采用倾向性评分匹配分析总生存。
- 另对监测、流行病学和最终结果数据库进行单独分析,评估首原发肺癌行肺段切除术与肺叶切除术患者中第二原发肺癌的治疗模式。
主要发现
- 国家癌症数据库共纳入23,286例符合标准患者,其中1397例(6.0%)行肺段切除术,21,889例(94.0%)行肺叶切除术。
- 倾向性评分匹配分析中,肺段切除术与肺叶切除术的总生存无显著差异(5年总生存79.9% [95% CI, 76.7%-82.0%] vs 81.8% [95% CI, 78.7%-84.4%],log-rank P=.72)。
- 按肿瘤分级和組織学亚组的分析中,肺段切除术与肺叶切除术的总生存相似。
- 监测、流行病学和最终结果数据库的倾向性评分匹配分析显示,首原发肺癌行肺段切除术与行肺叶切除术的患者在第二原发肺癌治疗模式上无显著差异。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The study objective was to identify whether the results of JCOG0802 could be generalized to US clinical settings. METHODS: Patients diagnosed with clinical stage IA (≤2 cm) non-small cell lung cancer who underwent segmentectomy versus lobectomy (2004-2017) in the National Cancer Database were identified. Overall survival of patients in the National Cancer Database was assessed using propensity score-matched analysis. A separate analysis of the Surveillance Epidemiology End Results database was conducted to evaluate treatment patterns of second primary lung cancers among patients who underwent segmentectomy versus lobectomy for a first primary lung cancer. RESULTS: Of the 23,286 patients in the National Cancer Database meeting inclusion criteria, 1397 (6.0%) underwent segmentectomy and 21,889 (94.0%) underwent lobectomy. In a propensity score-matched analysis of all patients in the study cohort, there were no significant differences in overall survival between patients undergoing segmentectomy versus lobectomy (5-year overall survival: 79.9% [95% CI, 76.7%-82.0%] vs 81.8% [95% CI, 78.7%-84.4%], log-rank: P = .72). In subgroup analyses by tumor grade and histologic subtype, segmentectomy was associated with similar overall survival compared with lobectomy in all subgroups evaluated. In a propensity score-matched analysis of patients in the Surveillance Epidemiology End Results database, there were no significant differences in treatment patterns of second primary lung cancers between patients who underwent segmentectomy and patients who underwent lobectomy for their first primary lung cancer. CONCLUSIONS: In this national analysis of US patients diagnosed with stage IA (≤2 cm) non-small cell lung cancer, there were no significant differences in overall survival between segmentectomy and lobectomy in the overall cohort or in subgroup analyses by tumor grade or histologic subtype.
引用
- Potter AL, Kim J, McCarthy ML, et al. Segmentectomy versus lobectomy in the United States: Outcomes after resection for first primary lung cancer and treatment patterns for second primary lung cancers. J Thorac Cardiovasc Surg. 2023. PMID: 37473997. doi:10.1016/j.jtcvs.2023.07.009
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。